BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 9778942)

  • 1. [Experimental studies of the protective effect of deferoxamine mesilate on cisplatin induced toxicity].
    Watanabe H; Kanno H
    Nihon Jibiinkoka Gakkai Kaiho; 1998 Aug; 101(8):967-78. PubMed ID: 9778942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental studies of the protective effect of ginkgo biloba extract (GBE) on cisplatin-induced toxicity in rats].
    Fukaya H; Kanno H
    Nihon Jibiinkoka Gakkai Kaiho; 1999 Jul; 102(7):907-17. PubMed ID: 10459293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An experimental study of the protective effect of lazaroid (U-74389G) on cisplatin-induced toxicity].
    Hori H; Kanno H
    Nihon Jibiinkoka Gakkai Kaiho; 1999 Jan; 102(1):8-18. PubMed ID: 10067316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Round window membrane delivery of L-methionine provides protection from cisplatin ototoxicity without compromising chemotherapeutic efficacy.
    Li G; Frenz DA; Brahmblatt S; Feghali JG; Ruben RJ; Berggren D; Arezzo J; Van De Water TR
    Neurotoxicology; 2001 Apr; 22(2):163-76. PubMed ID: 11405249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Deferoxamine protects against gentamicin ototoxicity].
    Chen Y; Wang J; Huang W
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Jun; 34(3):154-6. PubMed ID: 12764806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of combination of Ginkgo leaf extract and deferoxamine in preventing and treating ototoxicity of cisplatin].
    Xu O; Lu H; Li PQ; Zhang X; Lu Z
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Oct; 24(10):915-8. PubMed ID: 15553827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An experimental study of ototoxicity induced by deferoxamine mesilate].
    Yamanobe S; Kanno H
    Nihon Jibiinkoka Gakkai Kaiho; 1998 Aug; 101(8):979-87. PubMed ID: 9778943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of protective agents against cisplatin ototoxicity.
    Rybak LP; Husain K; Morris C; Whitworth C; Somani S
    Am J Otol; 2000 Jul; 21(4):513-20. PubMed ID: 10912697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salicylate protects hearing and kidney function from cisplatin toxicity without compromising its oncolytic action.
    Li G; Sha SH; Zotova E; Arezzo J; Van de Water T; Schacht J
    Lab Invest; 2002 May; 82(5):585-96. PubMed ID: 12003999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental study on effects of deferoxamine mesilate in ameliorating cisplatin-induced nephrotoxicity.
    Ozdemir E; Dokucu AI; Uzunlar AK; Ece A; Yaldiz M; Oztürk H
    Int Urol Nephrol; 2002; 33(1):127-31. PubMed ID: 12090318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of neomycin ototoxicity by iron chelation.
    Conlon BJ; Perry BP; Smith DW
    Laryngoscope; 1998 Feb; 108(2):284-7. PubMed ID: 9473083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research progress on mechanism of cisplatin ototoxicity and protective agents against the ototoxic effects].
    Liao YJ; Tang H
    Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):266-9. PubMed ID: 14628479
    [No Abstract]   [Full Text] [Related]  

  • 13. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
    Huang X; Whitworth CA; Rybak LP
    Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the effect of acetyl L-carnitine on experimental cisplatin ototoxicity and neurotoxicity.
    Gunes D; Kirkim G; Kolatan E; Guneri EA; Ozogul C; Altun Z; Serbetcioglu B; Yilmaz O; Aktas S; Mutafoglu K; Tufekci O; Erbayraktar Z; Olgun N
    Chemotherapy; 2011; 57(3):186-94. PubMed ID: 21525749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deferoxamine pretreatment prevents Cr(VI)-induced nephrotoxicity and oxidant stress: role of Cr(VI) chelation.
    Molina-Jijón E; Zarco-Márquez G; Medina-Campos ON; Zataraín-Barrón ZL; Hernández-Pando R; Pinzón E; Zavaleta RM; Tapia E; Pedraza-Chaverri J
    Toxicology; 2012 Jan; 291(1-3):93-101. PubMed ID: 22115772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels.
    Dickey DT; Wu YJ; Muldoon LL; Neuwelt EA
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1052-8. PubMed ID: 15951398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the protective effect of dexamethasone on cisplatin-induced ototoxicity in rats.
    Capelo IOJ; Batista AMA; Brito YNF; Diniz KB; Brito GAC; Freitas MR
    Acta Cir Bras; 2017 Oct; 32(10):873-880. PubMed ID: 29160374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of alpha-tocopherol on cisplatin-induced ototoxicity in guinea pigs.
    Teranishi M; Nakashima T; Wakabayashi T
    Hear Res; 2001 Jan; 151(1-2):61-70. PubMed ID: 11124452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against cisplatin ototoxicity by adenosine agonists.
    Whitworth CA; Ramkumar V; Jones B; Tsukasaki N; Rybak LP
    Biochem Pharmacol; 2004 May; 67(9):1801-7. PubMed ID: 15081879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar pharmacokinetics and differential ototoxicity after administration with cisplatin and transplatin in guinea pigs.
    Saito T; Zhang ZJ; Yamada T; Yamamoto T; Shibamori Y; Saito H
    Acta Otolaryngol; 1997 Jan; 117(1):61-5. PubMed ID: 9039483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.